Aptevo Therapeutics Inc (APVO) is a publicly traded Healthcare sector company. As of May 21, 2026, APVO trades at $4.57 with a market cap of $5.47M and a P/E ratio of -0.05. APVO moved +0.00% today. Year to date, APVO is -45.25%; over the trailing twelve months it is -95.92%. Its 52-week range spans $3.80 to $6,859.80. Analyst consensus is buy with an average price target of $21.00. Rallies surfaces APVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aptevo Therapeutics Inc (APVO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. APVO moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $4.57 |
| Market Cap | $5.47M |
| P/E Ratio | -0.05 |
| EPS | $-87.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $6,859.80 |
| 52-Week Low | $3.80 |
| Volume | 337 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-25.97M |
| Gross Margin | 0.00% |
1 analysts cover APVO: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $21.00.